# Rohto

Type: Company

Source: Supply Chain Intelligence Brief — https://getsupplybrief.com/entity/rohto
Canonical HTML page: https://getsupplybrief.com/entity/rohto

## Timeline

- **2026-08-24**: Recall ongoing — Reports confirm the recall is continuing as of August 24; Prestige spokesperson Phil Terpolilli reiterates consumer safety priority.
- **2026-08-22**: FDA Class II classification reported — An FDA enforcement report classifies the recall as Class II, indicating remote probability of serious adverse health consequences.
- **2026-07-29**: Voluntary recall initiated — Prestige begins a voluntary recall of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief, lot 2552A, due to lack of assurance of sterility.
- **2026-06**: Prestige completes $1.05B acquisition — Prestige Consumer Healthcare acquires the Breathe Right brand and other assets from Foundation Consumer Healthcare for approximately $1.05 billion.

## Recent coverage (1 stories)

### 39,060 Bottle Eye Drop Recall Signals Sterility Supply Chain Risk
2026-08-24 11:55:29 · Sentiment: Negative · Impact: 6/10 · Sources: 2

Prestige Consumer Healthcare's voluntary recall of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief, distributed by Medtech Products, highlights a sterility assurance breakdown in the ophthalmic supply chain. The Class II recall began July 29, covers lot 2552A expiring Sept. 30, 2027, and requires reverse logistics and traceability across retail channels.
Full story: https://getsupplybrief.com/story/supply-eye-drop-recall-39060-sterility

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getsupplybrief.com/guides/methodology for the full editorial methodology.